Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > PPS

<< Previous

Bullboard Posts

Next >>

Comment by JohnnyYegon Sep 29, 2023 11:52am

109 Views

Post# 35661797

RE:RE:RE:RE:RE:RE:PPS

I had to logout to see the comments of the id**ts I've blocked, and QueenTon has shown a new level of dumb with his obsession with tic tacs as a vehicle to scare off nervous investors for his MM overlords. Good lord - how pathetic.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec